Asadil, Absari U.

HRN: 28-34-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/28/2025
01/04/2026
IV
500mg
Q8
Intestinal Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines